Hi JDBLObviously the wrong thread to discuss but quickly ...I...

Hi JDBL

Obviously the wrong thread to discuss but quickly ...
I still hold 25% of my original holding.
The science is not only safe, it can be life changing ... but ... the management of, and relations with the FDA
cause me considerable concern.

I see IMU's relationship with the FDA, as the absolute opposite. My post yesterday highlighted the amazing 'flexibility'
the FDA affords IMU's recent trials around the CF33 suite. I don't think IMU are receiving any special treatment, I just
note (IMO) that the FDA is now very much prioritising promising cancer treatments, certainly where/when the scientific
team is structuring trials very soundly, while 'crossing every T and dotting every I' while staying in a regular 'dialogue' with
the governing body.
In my opinion, the IMU team is visionary, talented and well-balanced, and of course, working with an amazing IP suite
that continues to grow.

As always, my opinion only.